Eli Lilly's LLY short percent of float has risen 5.88% since its last report. The company recently reported that it has 6.10 million shares sold short, which is 0.72% of all regular shares that are ...

GlobalData analysts are predicting an Alzheimer’s disease market boom, tipping its value across major regions to increase ...

We recently compiled a list of the Jim Cramer Discusses Joe Rogan, Elon Musk, And These 13 Stocks. In this article, we are ...

Lilly seeks to protect interests in compounded drug case FDA affirms no shortage of tirzepatide drugs Compounded versions cheaper, often not covered by insurers Jan 2 (Reuters) - Eli Lilly (LLY.N ...

Eli Lilly and Co. said in October it will invest an additional $4.5 billion at its manufacturing site at the LEAP Research and Innovation District in Boone County to create a center for advanced ...

Eli Lilly and Co. CEO David Ricks—IBJ’s newsmaker of the year in 2023—returns to the newsmaker list in 2024 after a year that included a stock price that skyrocketed to an all-time high of $ ...

In the time since, though, some analysts have said the reaction is overblown, particularly for weight-loss drugmakers like Wegovy, and Ozempic maker Novo Nordisk and Zepbound maker Eli Lilly.

Novo's Ozempic is approved by the U.S. Food and Drug Administration (FDA) to treat diabetes, while Wegovy is primarily prescribed for obesity care. In the same vein, Lilly's Mounjaro is approved ...

The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro ... "FDA is aware that some patients and health care professionals may look to unapproved ...

Sophie and Rob further joked that Natalie was 90 years old and Sophie said that she didn't care. While in a joint confessional, the two further chimed in on the situation and Sophie said that ...

Okongwu is recognized for supporting Atlanta organizations that help those grieving the loss of loved ones. Official release Onyeka Okongwu is committed to supporting families dealing with the ...